Professor Steve Wilton
Professor Steve Wilton, along with colleague Professor Sue Fletcher, were early pioneers in the use of antisense oligomers to treat Duchenne muscular dystrophy (DMD). Three exon-skipping compounds from his group have now been approved by the US FDA to restore functional dystrophin expression in the most common mutations causing DMD. His research team is currently […]